Harmony (HRMY) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.28
- EPS estimate
- $0.96
- EPS surprise
- +33.85%
- Revenue surprise
- +4.19%
- Revenue
- $261.3M
- Revenue estimate
- $250.8M
- Reported
- Aug 4, 2026
Harmony Biosciences reported Q2 2026 results on August 4, 2026. Earnings per share were $1.28, ahead of the $0.96 estimate by 33.85%. Revenue was $261.3 million, 4.19% above the $250.8 million consensus. Compared with Q2 2025, EPS rose about 88% from $0.68 and revenue rose about 30% from $200.5 million.
Revenue has grown steadily across the table. Annual sales roughly doubled, from $437.8 million in 2022 to $868.5 million in 2025, and Q2 2026 set the quarterly high here. Earnings have been less even. Annual EPS was $3.13 in 2022, $2.12 in 2023, $2.51 in 2024 and $2.71 in 2025. The highest quarter in the table remains Q3 2022, at $1.44 per share. The two quarters before the latest one both missed estimates, with Q4 2025 at $0.38 and Q1 2026 at $0.55. Over the last 20 quarters, Harmony beat the EPS estimate 12 times and missed 8 times.
Harmony has reported Q3 results between October 29 and November 9 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the rebound in Q2 earnings carries into the second half of the year.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | $0.96 | $1.28 | +33.85% | $261.3M | SEC |
| Q1 2026 | May 7, 2026 | $0.69 | $0.55 | −20.83% | $215.4M | SEC |
| Q4 2025 | Feb 24, 2026 | $0.90 | $0.38 | −57.95% | $243.8M | SEC |
| Q3 2025 | Nov 4, 2025 | $0.81 | $0.87 | +7.26% | $239.5M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.70 | $0.68 | −3.48% | $200.5M | SEC |
| Q1 2025 | May 6, 2025 | $0.61 | $0.78 | +28.61% | $184.7M | SEC |
| Q4 2024 | Feb 25, 2025 | $0.73 | $0.85 | +15.80% | $201.3M | SEC |
| Q3 2024 | Oct 29, 2024 | $0.66 | $0.79 | +18.81% | $186.0M | SEC |
| Q2 2024 | Aug 6, 2024 | −$0.00 | $0.20 | +11864.71% | $172.8M | SEC |
| Q1 2024 | Apr 30, 2024 | $0.60 | $0.67 | +10.87% | $154.6M | SEC |
| Q4 2023 | Feb 22, 2024 | $0.72 | $0.45 | −37.67% | $168.4M | SEC |
| Q3 2023 | Oct 31, 2023 | $0.67 | $0.63 | −5.35% | $160.3M | SEC |
| Q2 2023 | Aug 1, 2023 | $0.61 | $0.56 | −8.02% | $134.2M | SEC |
| Q1 2023 | May 2, 2023 | $0.47 | $0.48 | +1.85% | $119.1M | SEC |
| Q4 2022 | Feb 21, 2023 | $0.58 | $0.79 | +35.20% | $128.3M | SEC |
| Q3 2022 | Nov 1, 2022 | $0.10 | $1.44 | +1287.28% | $117.2M | SEC |
| Q2 2022 | Aug 2, 2022 | $0.45 | $0.39 | −13.33% | $107.0M | SEC |
| Q1 2022 | May 3, 2022 | $0.29 | $0.51 | +74.12% | $85.3M | SEC |
| Q4 2021 | Feb 28, 2022 | $0.36 | $0.38 | +6.53% | $91.2M | SEC |
| Q3 2021 | Nov 9, 2021 | $0.28 | −$0.17 | −160.71% | $80.7M | SEC |
Quarterly revenue
Frequently asked questions
When did Harmony (HRMY) last report earnings?
Harmony last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did HRMY beat earnings estimates?
Yes. Harmony reported EPS of $1.28 for Q2 2026 against a $0.96 estimate — a 33.85% beat.
How much revenue did HRMY report last quarter?
Harmony reported $261.3M in revenue for Q2 2026, against a consensus estimate of $250.8M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.